Stratipath and Roche Join Forces to Help Expand Access to AI-Powered Precision Diagnostics

Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, is thrilled to announce a collaboration with Roche, the world's largest biotechnology company and the global leader in in-vitro diagnostics. In this non-exclusive collaboration, Roche will have the distribution rights to the integrated Stratipath solution, Stratipath Breast. The integration between Stratipath Breast and Roche's navify® Digital Pathology enterprise software enables Roche customers to seamlessly perform prognostic risk profiling analyses directly from navify® Digital Pathology platform.

Solna, 09/09/2024 (informazione.it - comunicati stampa - economia)

Stockholm - Sweden, Sept. 09, 2024 (GLOBE NEWSWIRE) --